Sorafenib plus memory like natural killer cell combination therapy in hepatocellular carcinoma is a research paper published in American Journal of Cancer Research (2024). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA209886
NCI NIH HHS
Grant: P30 CA062203
NCI NIH HHS
Grant: R01 CA241532
National Institutes of Health
Grant: 3P30CA062203-27S1
Clinical Trial Advancement and Development for Sarcomas
National Institutes of Health
Grant: 5R01CA241532-05
Image-guided Interventional Combination Liver Cancer Immunotherapy
National Institutes of Health
Grant: 7R01CA209886-06
MRI-Guided Dendritic-Cell-Based Vaccine Immunotherapy for Pancreatic Cancer
FWCI
2.32
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals